Facebook
Linkedin
Pinterest
Reddit
Twitter
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Search
Thoracolumbar Interbody
NuVasive’s Thoracolumbar Interbody Portfolio Receives First Clearance in the US for the Treatment of Sagittal Deformities
Nuvasive notes this clearance expands the portfolio's indications from one- to two-level spine surgery, to now multiple levels, for the treatment of sagittal malalignment.
November 9, 2020
Exit mobile version